Background: Long QT and use of QT-prolonging drugs are common among older patients receiving polytherapies, but real-world evidence on their impact in clinical practice is controversial. We investigated prevalence, variables associated and clinical implications of prolonged corrected QT (QTc) among patients from the Syncope and Dementia study. Methods: Observational, prospective, multicenter study. Patients≥65 years with dementia and fall suspected for syncope in the previous three months were enrolled. Several clinical variables and the complete list of medications were recorded for each patient. A 12-lead ECG was obtained and corrected QT was calculated by the Bazett's formula. One-year followup for death and recurrent syncope was performed. Results: Prolonged QTc was observed in 25% of the 432 enrolled patients (mean age 83.3), and was significantly associated with male gender (OR 2.09; 95% CI 1.34-3.26) and diuretics use (OR 1.85; 95% CI 1.18-2.90). At one-year 23.3% of patients died and 30.4% reported at least one recurrent event. Variables associated with oneyear mortality were: age, male gender, atrial fibrillation (AF), use of calcium channel blockers and prolonged QTc (OR 1.80; 95% CI 1.01-3.20). Among patients with prolonged QTc a significant interaction for mortality was found with AF. Recurrent events were associated with the use of antiplatelets, cholinesterase.
including electrolyte imbalance, cardiac ischemia and structural heart disease and drugs [1, 2] .
Older age by itself is a risk factor for QT prolongation [3] [4] [5] [6] [7] ; moreover age-associated conditions such as presence of dementia and polypharmacy make elderly patients at increased exposure to QT prolonging drugs and consequently at risk of adverse associated outcomes [8, 9] . However, to the best of our knowledge, there are limited data about prevalence and prognostic implications of prolonged QT in real-world older patients.
The "Syncope and Dementia" study (SYD) was designed by the Italian Group for the study of Syncope with the endorsement of the Italian Geriatric Society in order to evaluate older patients with dementia and suspected syncope or unexplained falls [10] . Advanced age, the presence of dementia and the use of multiple medications, including antipsychotics and antidepressants, make these patients a potentially interesting target to investigate prevalence and clinical implications of prolonged QTc (corrected QT).
Accordingly, the aims of the present study were: i) to investigate prevalence and variables associated with prolonged QTc in older patients with dementia, and ii) to evaluate whether prolonged QTc was associated with death and recurrence of syncope and falls at one-year.
Methods
This is a secondary analysis of the SYD [10] dataset, that was a prospective observational study involving nine Italian departments of Geriatrics. The overall study population consisted of 522 in-and outpatients aged ≥65 years referring to acute care wards, syncope units or Alzheimer's evaluation units. The full study design, including the standardized multidimensional geriatric assessment and the diagnostic protocol applied for the diagnosis and management of syncope, has been described elsewhere [10, 11] . Briefly, consecutive patients with a diagnosis of dementia, according to the Diagnostic and Statistical Manual of Mental Disorders IV [12] , and at least one episode of suspected syncope or unexplained fall during the previous three months, were enrolled. Informed consent was obtained from each patient. The study protocol was approved by the Ethic Committee of the University of Naples and then by each local ethical committee.
At their first visit patients underwent a full diagnostic evaluation, including a 12-leads-ECG, which was tape-recorded for further revision. The QT interval was measured from the onset of QRS complex to the end of the T wave (the intersection between the T wave tangent, drawn at its maximum down slope, and the isoelectric line), and corrected for the previous cardiac cycle length according to the Bazett's formula [13] . An averaged QT measure over 3 to 5 beats in a single lead was calculated both in patients with sinus rhythm and in those presenting with atrial fibrillation (AF) [14] preferably using either lead II or lead V5. All measurements where revised by an experienced cardiologist (MB). Patients with pace-maker and subjects without valid QTc measurements were excluded from this analysis. Prolonged QTc was defined using a threshold value of 450 milliseconds (ms) in males and 460 ms in females [15] .
The presence of comorbidities was investigated and their number and severity were scored according to the Cumulative Illness Rating Scale (CIRS) [16, 17] . A complete list of pharmacological treatment, coded according to the Anatomical Therapeutic and Chemical codes [18] was collected for each patient; particular attention was given to medications potentially prolonging QTc interval, including antipsychotics and antidepressants [19] .
One year follow-up was conducted through planned visit or phone interviews with patients' main caregiver, aiming to ascertain vital status and recurrence of syncope or unexplained falls. For patients reporting recurrent clinical events, medical documentation was obtained in order to confirm the diagnosis.
Mean 
Results
From February 2012 to October 2016, a total of 522 patients were enrolled in the SYD study. Subjects without valid QTc measurements were excluded, leaving a sample of 432 patients available for this study. Main demographic and clinical characteristics of the overall sample of patients and in those with and without prolonged QTc are reported in Table 1 . In the overall sample, mean age was 83.3 ± 6.2 years and 38.7% were males, with high prevalence of comorbidities and poor level of basic and instrumental functional autonomy (Activities of Daily Living scale (ADL) and Instrumental Activities of Daily Living scale (IADL). The mean number of daily taken drugs was of 5.98 ± 2.81; psychoactive medications were widely used, including antipsychotics (24.5%), antidepressants (33.8%) and benzodiazepines (21.3%). The average heart rate was 74.4 ± 15.1, and AF was present in 14.4% of patients. The mean QTc length was 436.1 ± 26.6 ms and prolonged QTc was observed in 25% of patients.
At univariate analysis, prolonged QTc was associated with male gender (p = .001), use of diuretics (p = .008) and insulin (p = .024), orthostatic hypotension (p = .006), AF (p = .037), heart rate (p < .0001) and CIRS Severity Index (p = .01) ( Table 1 ). After stepwise multiple linear regression analysis, only male gender (Odds Ratio (OR) 2.09, 95% CI 1.34-3.26) and diuretic use (OR 1.85, 95% CI 1.18-2.9) were significantly associated with a prolonged QTc.
Complete follow-up data at one year were not available for 77 patients, who were excluded from further analysis. Among the 355 remaining patients, 83 patients (23.3%) died (35.6% among patients with prolonged QTc and 19.3% among patients with normal QTc), while recurrence of syncope or unexplained fall was observed in 108 patients (30.4%). Variables associated with one-year mortality and recurrence of syncope or unexplained fall are reported in Table 2 . After stepwise multiple logistic model analysis (model 1) prolonged QTc was significantly associated with all-cause mortality at one-year (OR 1.80; 95% CI 1.01-3.20), along with age, male gender, AF and use of calcium channel blockers (Table 3) .
Among patients with prolonged QTc, several variables were significantly associated with one-year mortality: male gender (OR 3.97; 95% IC 2.10-7.52), congestive heart failure (OR 5. (model 2) only the interaction between the presence of AF and prolonged QTc was found to be significantly associated with death, along with male gender, age and use of calcium channel blockers (Table 3) .
No association was observed between prolonged QTc and recurrence of syncope or unexplained fall, which were significantly associated with the use of antiplatelets (OR 1.72; 95% CI 1.07-2.76), cholinesterase inhibitors (OR 1.86; 95% CI 1.01-3.44) and antipsychotics (OR 1.84; 95% CI 1.11-3.07).
Discussion
In a sample of older patients admitted for syncope or unexplained falls we observed these main clinical findings: i) a high prevalence of prolonged QTc interval, with one fourth of patients affected; ii) a significant association of prolonged QTc with male gender and diuretic use, but not with other specific drug-classes, including antipsychotics; iii) prolonged QTc (along with male gender, increasing age, use of calcium channel blockers and AF) was associated with higher one-year mortality, with a four-fold increased risk in patients with concomitant AF.
The prevalence of prolonged QTc observed in our sample is in keeping with previous studies. Among 537 medical inpatients (70% aged over 65 years), Pasquier et al. observed a prevalence of prolonged QT of 22.3% [20] , whereas Maison and colleagues reported a prevalence of 22% in a sample of older hospitalized patients, with a mean age of 87 years [21] .
With respect to determinants of prolonged QTc, several factors have been reported in literature [22, 23] , including advancing age, female gender and drug therapies. Although QT interval is usually longer in adult women than in men until the sixth decade [5, 24] , only few studies have investigated QT length in older patients [23] . In our sample of elderly patients, we observed an association between male sex and prolonged QTc (OR 2.09, 95% CI 1.34-3.26). Our findings are in keeping with the study of Maison et al., that reported an increased prevalence of prolonged QT in older males (OR 3.25, 95%CI 1.43-7.41) [21] . Age-associated modifications of sex-steroid hormones might affect cardiac repolarization; several studies have reported that lower levels of testosterone were associated with longer QTc interval. [25] [26] [27] .
In a sample of older patients with high prevalence of polypharmacy and wide use of several drugs with potential QT prolonging effect, only diuretics were significantly associated with prolonged QTc. More than one-third of study patients were treated with diuretics, mainly thiazides and furosemide. This association could be explained by diuretics effects on potassium homeostasis [3, 7, 28, 29] , even if a causal relationship is QTc: corrected QT; AF: Atrial Fibrillation.
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not defined. It has been suggested that QT interval prolongation might be at least in part due to diuretic-induced hypomagnesemia, but there are no definite data at this regard [22, 29] . Certainly both conditions are very frequent in older individuals, that are particularly vulnerable to the depleting effects of diuretics. In this sample of older patients with dementia, antipsychotic drugs, although widely used, were not associated with prolonged QTc interval. Results did not differ analyzing separately typical and atypical antipsychotic drugs (data not shown). Although there is no doubt that antipsychotic drugs have the potential to cause arrhythmias, the ion channel effects of most drugs are relatively weak [30] [31] [32] [33] , and it is possible that these medications do not intrinsically prolong the QTc interval [34] . Moreover, QTc by itself is a weak predictor of torsade de pointes and sudden cardiac death [35] , and there is no clear consensus on the correct approach for managing QT-prolonging risk with antipsychotics [30] . However, in the present study we were not able to identify sudden death events, thereby reducing clinical implications of present findings.
In our analysis prolonged QTc, and QTc prolongation with concomitant AF, were associated with a two-fold and more than four-fold increased risk of all-cause mortality, respectively. Our findings add on and reinforce previous studies which demonstrated that long QTc is a risk factor for all-cause mortality [23, 28, 34] . Several studies confirmed this association among adult patients in different clinical settings, with risk of all-cause mortality approximately triplicated, as well in older patients [36] [37] [38] [39] [40] . Pickham et al. [36] reported a risk of all-cause mortality approximately triplicated in a cohort of intensive care unit adult patients. Nakanishi et al. [37] demonstrated that individuals with prolonged QT have a two-fold increased risk of death in a sample of 3543 elderly Japanese patients. In the Rotterdam study (3484 patients, mean age 69.1, SD 8.1 years) QT prolongation was associated with a two-fold increased risk of mortality, with a significant increased risk of sudden cardiac death only in participants with a consistently prolonged QT defined as presence of a prolonged QT on two consecutive electrocardiograms [39] . However, some of these studies [37, 40] excluded patients who were taking medications potentially associated with increased risk of prolonged QT, and no study used a comprehensive multidimensional evaluation; present findings, demonstrating a significant association of prolonged QTc with mortality on top of a standardized cardiologic protocol and a multidimensional geriatric assessment, confirm the robustness and strength to this association.
In our study, AF was found to be an important risk factor for death in both models, and QTc prolongation with concomitant AF was associated with a more than four-fold increased risk of mortality. Concomitant prolonged QTc interval and AF might be expression of an increased severity of structural cardiac disease, thereby underlying increased individual vulnerability and risk of death. Moreover, the presence of both these conditions has been reported to be associated with a five-fold enhanced risk of heart failure [41] . Unfortunately, we were not able to ascertain the cause of death in study patients; further prospective studies should address this causal association in older polymorbid patients.
Calcium channel blockers were the only drug class associated with a statistically significant increased risk of mortality in our study, which was more than doubled in patients receiving these drugs (OR 2.18 and OR 2.26 in model 1 and model 2, respectively). In literature there is scant evidence about this issue and, moreover, in our study calcium channel blockers were considered all together, without differentiating between dihydropyridinic and non-dihydropyridinic ones. Data are intriguing but despite the observational prospective design, the comprehensive multidimensional assessment and the statistical analysis, we can't definitively exclude a chance result.
Finally, prolonged QTc interval was not significantly associated with recurrent events, which were significantly more frequent in patients treated with antiplatelet drugs, cholinesterase inhibitors and antipsychotics. Use of cholinesterase inhibitors and antipsychotics might suggest a more advanced stage of dementia, with behavioral symptoms, thereby portending an increased risk of recurrent events, mainly falls. It is more difficult to find explanations for the observed association of antiplatelet drugs with recurrent events, which remained significant after correcting for cardiovascular variables such as history of stroke, TIA or ischemic heart disease. Use of antiplatelet drugs might be a surrogate of perceived increased risk of cardiovascular events or of vascular dementia, this latter being associated with an increased risk of falls. However, a causal relation seems unlikely.
In our view, the present prospective study has several strengths, including the multicenter enrollment, the standardized cardiologic evaluation and the comprehensive multidimensional geriatric assessment. Therefore, patients enrolled may be considered representative of the vast group of real world older in-and out-patients with dementia admitted for suspected syncope. For the same reasons, these findings should not be generalized to "healthier" elderly subjects without cognitive impairment and with better clinical and functional status. Some limitations should be considered too. Firstly, we were not able to ascertain specific cause of death in all patients and, therefore, we could not discriminate how much sudden cardiac death contributed to overall mortality and whether prolonged QTc was associated also with increased risk of sudden death, thus potentially reducing clinical implications of the present findings. However, the principal aim of this study was to evaluate whether QTc prolongation was significantly associated with increased overall mortality (or recurrent events), despite the multiple concurrent potential causes of death and falls among these older and vulnerable patients. Secondly, as discussed above, we could not evaluate potential modifications of QTc length during follow up, thereby making impossible to ascertain whether further prolonging of QTc length occurred in patients with adverse outcomes. Therefore, despite the well documented potential causal link and the independent association observed, whether QTc interval prolongation is a risk factor for, rather than a marker of, increased mortality risk in these patients remains a matter of discussion. Although other formulas are available for QTc measurement, the Bazett's formula (which does not correct for gender and might under-and overestimate QTc at very low and very high heart rate) is currently one of the most widely used in clinical practice. By the way, in our sample of patients medium heart rate was 74.4, and only 78 patients (18%) had heart rate lower than 60 bpm or higher than 100 bpm. Indeed, results did not significantly change when the analysis was performed using the method proposed by Sagie et al. [42] . Moreover, although the severity of QT prolongation has clinical relevance, we deliberately did not consider the association between absolute QTc intervals and prolonged QTc, since in clinical practice physicians usually rely on prolonged QTc rather than on its absolute value.
Despite these limitations, our findings have potential clinical implications. Dementia and cognitive impairment are common chronic conditions affecting older individuals and, in these patients, falls and suspected syncope are frequent cause of admission to hospital [43] [44] [45] . Most of these vulnerable patients usually are treated with one or more psychoactive medications and other concomitant drug therapy potentially associated with QTc prolonging effect [30, 46] . Our findings suggest that diuretics, rather than antipsychotics, are closely associated with prolonged QTc in these patients. Therefore, present findings suggest the need of a careful and inclusive review of all drug therapies potentially implicated with prolonged QTc and of regular ECG monitoring in these older patients receiving polypharmacy.
Conclusions
In this cohort of older patients with dementia and suspected syncope, we demonstrated a high prevalence of prolonged QTc, that was associated with male gender and diuretic use. QTc prolongation, by itself and with concomitant AF, was associated with a two-fold and four-fold increased risk of mortality, respectively.
